Business · 07/04/2006Updated: 10/17/2026 · 1 min read
FDA Amends Animal Drug Regulations for New Bacitracin Methylene Disalicylate and Streptomycin Sulfate Oral Powder
Summary
The FDA is updating its regulations to reflect a change in sponsorship for a new animal drug application for a powder containing bacitracin methylene disalicylate and streptomycin sulfate, which will now be developed by Alpharma Inc. instead of Veterinary Specialties, Inc.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →